Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TFPI | P10646 | 1/20 | 0.47 |
| ▸ | TASP1 | Q9H6P5 | 1/20 | 0.46 |
| ▸ | NPY4R | P50391 | 8/20 | 0.46 |
| ▸ | NPY1R | P25929 | 6/20 | 0.46 |
| ▸ | NPY2R | P49146 | 4/20 | 0.46 |
| ▸ | NPY5R | Q15761 | 4/20 | 0.46 |
| ▸ | BACE1 | P56817 | 5/20 | 0.45 |
| ▸ | VIPR1 | P32241 | 1/20 | 0.44 |
| ▸ | BACE2 | Q9Y5Z0 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29837350 | 0.98 | TFPI (0.47) | TFPITASP1NPY4RNPY1RNPY2R | |
| SCHEMBL29837349 | 0.97 | TFPI (0.46) | TFPITASP1NPY4RNPY1RNPY2R | |
| SCHEMBL29625167 | 0.94 | NPY4R (0.49) | TFPINPY4RNPY1RNPY2RNPY5R | |
| SCHEMBL30262050 | 0.93 | TFPI (0.50) | TFPIBACE1VIPR1BACE2 | |
| SCHEMBL29696019 | 0.92 | NPY4R (0.49) | TFPINPY4RNPY1RNPY2RNPY5R | |
| SCHEMBL31666006 | 0.91 | NPY4R (0.50) | NPY4RNPY1RNPY2RNPY5RBACE1 | |
| SCHEMBL30381394 | 0.91 | TASP1 (0.49) | TFPITASP1NPY4RNPY1RNPY2R | |
| SCHEMBL31461989 | 0.91 | TASP1 (0.47) | TASP1BACE1VIPR1 | |
| SCHEMBL30768183 | 0.91 | BACE1 (0.53) | TFPINPY4RNPY1RNPY2RNPY5R | |
| SCHEMBL31019331 | 0.91 | VIPR1 (0.53) | TFPITASP1VIPR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240252516-A1 | COMBINATION BPH THERAPY WITH FEXAPOTIDE TRIFLUTATE, A 5-ARI, AND AN ALPHA BLOCKER | NYMOX CORPORATION | 2024-08-01 | — | — | US | disclosed |
| CN-110381984-B | Compositions and methods for improving sexual function | 尼莫克斯股份有限公司 | 2023-11-28 | — | — | CN | disclosed |